Minimisation of the viral contamination risk of heterologous immunoglobulins in the context of the requirements of the State Pharmacopoeia of the Russian Federation [PDF]
To ensure the safety and to secure the approval of injectable medicinal products based on antigen-specific immunoglobulins of animal origin, it is necessary to exclude their contamination with adventitious human pathogens.
V. V. Mashin +6 more
doaj +6 more sources
Outdated latin names of medicinal plants in the monographs of the State Pharmacopoeia of the Russian Federation, XIV edition (review) [PDF]
Introduction. The State Pharmacopoeia of the Russian Federation, XIV-th edition (SP XIV), includes 107 monographs devoted to medicinal plant materials. The purpose of the study was to identify incorrect Latin names of medicinal plants in the monographs ...
M. N. Povydysh, M. Yu. Goncharov
doaj +4 more sources
A Risk-Based Approach to Planning the Elaboration of Pharmacopoeial Monographs [PDF]
Scientific relevance. This article describes a risk-based analysis of the need for elaborating pharmacopoeial requirements for 6 therapeutic groups of medicines, including an evaluation of the range and number of batches of these medicines put into the ...
A. V. Yarutkin, V. L. Bagirova
doaj +3 more sources
NMR as Used in the Russian and Foreign Pharmacopoeias for Quality Control of Medicinal Products [PDF]
The ongoing development of the Pharmacopoeia of the Eurasian Economic Union and the current trend for harmonisation of the Russian Pharmacopoeia with the world leading pharmacopoeias suggest the necessity of studying how different pharmacopoeias use ...
S. V. Moiseev +2 more
doaj +3 more sources
State Pharmacopoeia of the Russian Federation Edition XV: Development Priorities
INTRODUCTION. Regular reviews of the current portfolio of general chapters and monographs are essential to ensure the well-balanced development of the State Pharmacopoeia of the Russian Federation (Ph.
A. V. Yarutkin, V. L. Bagirova
doaj +2 more sources
Recommendations on Describing the Requirements for Microbiological Quality and Sterility of Medicinal Products [PDF]
The paper presents recommendations on describing analytical procedures for evaluation of medicinal products in terms of sterility and microbiological quality in accordance with the State Pharmacopoeia of the Russian Federation and the Pharmacopoeia of ...
O. V. Gunar
doaj +3 more sources
Comparison of the World Pharmacopoeias’ Requirements for the Quality of Cell Lines [PDF]
The cell line is one of the necessary components of a biomedical cell product (BMCP) which can include only viable human cells. In addition, human, animal, insect, or bacterial cell lines can be used as a substrate for the production of some biological ...
M. A. Vodyakova +3 more
doaj +3 more sources
Control of Organic Impurities in Semisynthetic Antibiotics [PDF]
In 2012, the European Medicines Agency (EMA) adopted a guideline, which divided all antibiotics into groups according to the manufacturing process and established acceptance criteria for organic impurities for each of the groups.The aim of the study was ...
E. L. Kovaleva +4 more
doaj +4 more sources
Practical Aspects of Processing and Interpretation of the Results of Microbiological Analysis of the Quality of Non-Sterile Medicines [PDF]
The article presents materials on processing and interpretation of the results of microbiological analysis of the quality of medicines in accordance with the State Pharmacopoeia of the Russian Federation and the Pharmacopoeia of the Eurasian Economic ...
O. V. Gunar
doaj +3 more sources
The State Pharmacopoeia of the Russian Federation is a collection of general monographs and pharmacopoeial monographs. It should be reissued at least once in 5 years.
V. A. Merkulov +4 more
doaj +1 more source

